Abstract:
PURPOSE: A composition for preventing or treating obesity or type 2 diabetes is provided to reduce body weight and epididymis fat and carnitine, neutral lipid and blood cholesterol. CONSTITUTION: A composition for preventing or treating obesity or type 2 diabetes contains Jerusalem artichoke powder or extract as an active ingredient. The Jerusalem artichoke extract is contained in 0.01-5.99 weight%(w/w) of total diet. The composition increases carnitine content in blood or liver. The carnitine is increased by high expression of carnitine palmitoyltransferase-I.
Abstract:
A method for maturing and preparing the black garlic, and the black garlic prepared by the method are provided to reduce the maturation time of garlic and to improve productivity. A method for maturing and preparing the black garlic comprises the steps of putting the raw garlic whose skin is removed in a sterilization pot and steaming the garlic; and maturing the steamed garlic in a thermo-hygrostat to prepare the steamed black garlic. Preferably the raw garlic is steamed at a temperature of 100±1 deg.C for 10-15 min.
Abstract:
PURPOSE: A hangover-relieving agent containing flavonoid is provided to suppress ROS generation and to prevent apoptosis of hepatocytes. CONSTITUTION: A hangover-relieving agent containing flavonoid is prepared by adding 1-10 weight% of taurine to extract mixture of 5-10 weight% of Scutellaria baicalensis, 5-10 weight% of Taraxacum platycarpum, 10-20 weight% of Alnus japonica Steude, 5-15 weight% of Puerariae radix, 1-10 weight% of red ginseng, 1-10 weight% of malt, 1-10 weight% of Aurantii nobilis Pericarpium, 1-10 weight parts of Artemisiae capillaries herba, 1-5 weight% of Atractylodes macrocephala Koidzumi, and 1-5 weight% of Beckmannia syzigachne.
Abstract:
본 발명은 다슬기를 유효성분으로 하는 생약 추출물을 함유하는 간질환 치료용 약제 조성물에 관한 것이다. 보다 상세하게는, 다슬기를 유효성분으로 하는 생약추출물이 간섬유화를 감소시키고, 간세포주(HepG2)에서 타크린으로 유발된 세포독성을 개선시키는 작용을 하는 간섬유화 및 간세포 손상치료용 약제 조성물에 관한 것이다. 다슬기 * 인진쑥 * 생약혼합 추출물 * 간세포 * 간 섬유화
Abstract:
The present invention relates to an anti-hemolytic composition comprising more than one extract of Carpesii fructus and Farfarae flos as active ingredients, specifically to an anti-hemolytic composition which contains extracts of Carpesii fructus and Farfarae flos and controls the generation of erythrocytolysis induced by 2,2′-azobis (2-amidinopropane) dihydrochloride (AAPH) and the generation of malondialdehyde (MDA) which is a final product of a lipid oxidation material of plasma. [Reference numerals] (AA) Hemolysis rate(%); (BB) Normal control group; (CC) Negative control group; (DD) Carpesii Fructus; (EE) Farfarae Flos; (FF) Positive control group; (GG) Extract[關g/mL]
Abstract:
PURPOSE: A composition containing a Cirsium japonicum extract for suppressing activation of hepatic stellate cells is provided to prevent and treat chronic liver diseases. CONSTITUTION: A composition for suppressing activation of hepatic stellate cells contains 1-100 mg/kg of a Cirsium japonicum extract. The composition is a health food. The Cirsium japonicum extract suppresses proliferation of hepatic stellate cells, caused by platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta).